Acquires facility in Oxfordshire and will invest up to $160 million to complete and equip it with state-of-the-art capabilities for biologics and vaccines.
Aamir Malik of Pfizer discusses the role of mRNA in vaccines and future drug development, partnerships, and the role of manufacturing in product innovation.
DFE Pharma’s CEO Martti Hedman discusses the partnership established by DFE Pharma, Harro Höfliger, and Sterling, in the field of dry powder inhalation.
Lonza will provide kilogram-scale synthesis, purification and stability testing of Cantrixil, and deliver cGMP batches of drug substance for clinical supply.